Wells Fargo Q4 Profit Tops View, But Revenues Miss

Wells Fargo & Co. (WFC) reported that its fourth-quarter net income rose to $2.99 billion or $0.64 per share from $2.87 billion or $0.60 per share in the prior year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.60 per share for the fourth-quarter. Analysts' estimates typically exclude special items.

Provision for credit losses decreased $823 million, predominantly due to a $757 million reserve release due to the announced sale of our student loan portfolio, as well as lower net charge-offs.

Net interest income decreased 17% year-over-year to $9.28 billion, primarily due to the impact of lower interest rates, lower loan balances primarily due to weak demand and elevated prepayments, lower investment securities balances, and higher mortgage-backed securities premium amortization.

Non-interest income slightly declined to $8.65 billion from $8.66 billion last year.

Quarterly total revenues for the quarter decreased to $17.93 billion from $19.86 billion in the previous year. Analysts expected revenues of $18.13 billion for the quarter.

The company's board approved an increase in the company's authority to repurchase common stock by an additional 500 million shares, bringing the total authorized amount to 667 million common shares.

In Friday pre-market trading, WFC was trading at $33.50, down $1.26 or 3.62 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT